Nerve growth factor inhibits PC12 cell PDE 2 phosphodiesterase activity and increases PDE 2 binding to phosphoproteins

Journal of Neurochemistry

Volumn 76, Issue 4, 2001, Pages 1252-1263

  Kelley Bentley, J ^a   Juilfs, Dawn M ^a,b   Uhler, Michael D ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c PFIZER INC   (United States)

Author keywords

3 ,5 cyclic nucleotide phosphodiesterase; Cyclic AMP; Cyclic GMP; Nerve growth factor; PC12 cells; PDE 2; Phosphoprotein

Indexed keywords

CYCLIC AMP; CYCLIC GMP; MESSENGER RNA; NERVE GROWTH FACTOR; ORTHOVANADIC ACID; PHOSPHODIESTERASE; PHOSPHODIESTERASE 2; PHOSPHOPROTEIN; PHOSPHORUS 32; PHOSPHOSERINE; PHOSPHOTHREONINE; PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL INTERACTION; CELL STRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; GENETIC TRANSFECTION; HYDROLYSIS; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; AUTORADIOGRAPHY; CYCLIC AMP; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; NERVE GROWTH FACTOR; NEURITES; PC12 CELLS; PHOSPHODIESTERASE INHIBITORS; PHOSPHOPROTEINS; PHOSPHORIC DIESTER HYDROLASES; PHOSPHORUS RADIOISOTOPES; PROTEIN-TYROSINE-PHOSPHATASE; RATS; RECOMBINANT PROTEINS; RNA, MESSENGER; TIME FACTORS;

ANIMALIA;

EID: 0035109972     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00133.x     Document Type: Article

References (43)

1. Nerve growth factor treatment enhances nicotine-stimulated dopamine release and increases in cyclic adenosine 3′: 5′-monophosphate levels in PC12 cell cultures
2. Molecular cloning of cDNA encoding a '63'-kDa calmodulin-stimulated phosphodiesterase from bovine brain
3. Practical approaches to molecular cloning of nicotinic acetylcholine receptor genes
4. Activation of phosphodiesterase IV during desensitization of the A2A adenosine receptor-mediated cyclic AMP response in rat pheochromocytoma (PC12) cells
5. Identification of a noncatalytic cGMP-binding domain conserved in both the cGMP-stimulated and photoreceptor cyclic nucleotide phosphodiesterases
6. Chelerythrine, a protein kinase C inhibitor, interacts with cyclic nucleotide phosphodiesterases
7. Use of vanadate as protein-phosphotyrosine phosphatase inhibitor
8. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor
9. PC12 pheochromocytoma cells: Culture, nerve growth factor treatment, and experimental exploitation
10. Extracellular-signal-regulated kinase signaling in neurons
11. Differential and synergistic actions of nerve growth factor and cyclic AMP in PC12 cells
12. Phosphorylation-dependent inhibition of protein phosphatase-1 by G-substrate
13. Affinities of bovine photoreceptor cGMP phosphodiesterases for rod and cone inhibitory subunits
14. Synergistic effects of cyclic AMP and nerve growth factor on neurite outgrowth and microtubule stability of PC12 cells
15. Nitric oxide donors enhance neurotrophin-induced outgrowth through a cGMP-dependent mechanism
16. Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling
17. A subset of olfactory neurons that selectively express cGMP-stimulated phosphodiesterase (PDE2) and guanylyl cyclase-D define a unique olfactory signal transduction pathway
18. Neurotrophin signal transduction in the nervous system
19. A family of cAMP-binding proteins that directly activate Rap1
20. Neurotrophin induced cAMP and IP3 responses in PC12 cells. Different pathways
21. Nerve growth factor decreases soluble guanylate cyclase in rat pheochromocytoma PC12 cells
22. Characterization of particulate cyclic nucleotide phosphodiesterases from bovine brain: Purification of a distinct cGMP-stimulated isoenzyme
23. Differential inhibition of multiple cAMP phosphodiesterase isozymes by isoflavones and tyrphostins
24. Both neuronal NO synthase and nitric oxide are required for PC12 cell differentiation: A cGMP independent pathway
25. Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine
26. A cyclic GMP stimulated cyclic nucleotide phosphodiesterase gene is highly expressed in the limbic system of rat brain
27. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons
28. Epac is a Rap1 guanine nucleotide-exchange factor directly activated by cyclic AMP
29. Isolation and characterization of human cDNAs encoding a cGMP-stimulated 3′,5′-cyclic nucleotide phosphodiesterase
30. Differential expression of the cyclic GMP-stimulated phosphodiesterase PDE 2A in human venous and capillary endothelial cells
31. SMART: A Web-based tool for the study of genetically mobile domains
32. Measurement of protein using bichinchoninic acid
33. Regulation of cAMP and cGMP signaling: New phosphodiesterases and new functions
34. Molecular cloning of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase cDNA. Identification and distribution of isozyme variants
35. Structure and function studies of the cGMP-stimulated phosphodiesterase
36. Use of T7 RNA polymerase to direct expression of cloned genes
37. Purification and partial characterization of membrane-associated type II (cGMP-activatable) cyclic nucleotide phosphodiesterase from rabbit brain
38. Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells
39. Optimization of asymmetric polymerase chain reaction for rapid fluorescent DNA sequencing
40. The calmodulin-dependent phosphodiesterase gene PDE 1C encodes several functionally different splice variants in a tissue specific manner
41. A novel cyclic GMP stimulated phosphodiesterase from rat brain
42. The cyclic adenosine monophosphate-dependent protein kinase (PKA) is required for sustained activation of mitogen-activated kinases and gene expression by nerve growth factor
43. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor